San Francisco Bay Area Biometrics Consulting
Request a Consultation Pharma Recruiting  Contact Us Iphone  925-320-7600 
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
San Francisco Bay Area Biometrics Consulting
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZlcnNpb249IjEuMCIgd2lkdGg9IjkwMCIgaGVpZ2h0PSIzMDAiID48L3N2Zz4=

Industry Solutions

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTYiIGhlaWdodD0iMTYiIHZpZXdCb3g9IjAgMCAxNiAxNiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNMTEuNTggNy4wM0w1LjMwMiAyLjE2NUM1LjE2NSAyLjA1NyA1LjAxNiAyIDQuODU3IDIgNC4zODQgMiA0IDIuNTA0IDQgMy4xMjV2OS43NWMwIC42Mi4zODQgMS4xMjUuODU3IDEuMTI1LjE2IDAgLjMwOC0uMDU3LjQzNi0uMTU2TDExLjU4IDguOTdjLjI1LS4xOTguNDItLjU1OC40Mi0uOTcgMC0uNDEyLS4xNy0uNzczLS40Mi0uOTd6IiBmaWxsPSIjZmZmZmZmIiBvcGFjaXR5PSIwLjgiIGZpbGwtcnVsZT0iZXZlbm9kZCIvPjwvc3ZnPg==data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTYiIGhlaWdodD0iMTYiIHZpZXdCb3g9IjAgMCAxNiAxNiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNNCAydjEyaDNWMkg0em01IDB2MTJoM1YySDl6IiBmaWxsPSIjZmZmZmZmIiBvcGFjaXR5PSIwLjgiIGZpbGwtcnVsZT0iZXZlbm9kZCIvPjwvc3ZnPg==
Curved
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZlcnNpb249IjEuMCIgd2lkdGg9IjEyMDAiIGhlaWdodD0iMjc1IiA+PC9zdmc+

Biopharma Industry Solutions

The journey of a novel pharmacological or biological therapeutic to market is one of many obstacles.  Only 9% of new molecules and biologics make it to Phase III of clinical trials.  From drug discovery to FDA approval, developing a new medicine on average takes 10 years, with a cost of $2.6 billion, which includes the cost of many potential medicines that do not make it through FDA approvals. In spite of these tremendous challenges, biopharmaceuticals companies have developed many Innovative Medicines that have drastically improved patient’s health and saved lives. We, at Clindata Insight, are committed to applying the latest statistical and computational science to support biopharma to advance the pipeline and to serve patients world wide. We are experienced with New Drug Application (NDA) of small molecule trials as well as oncology trials to FDA Center for Drug Evaluation and Research (CDER) and Biologics Licensing Application (BLA)  for biologics trials to FDA Center for Biologics Evaluation and Research (CBER).  We are equipped and prepared to bring in statistical and programming expertise and help you manage data-related challenges throughout this substantial undertaking, whether it is trial design issue, obtaining the necessary talent for various projects, submission data strategy,  or FDA clinical data structure compliance, we can catalyze specific stages of your pathway to success.

 

 

 

 

Ready to Get Started?

Schedule a No Obligation Consultation with a Clindata Insight Representative Today

Admin
21 July 2016
Kevin Durant, one of the best basketball players in the NBA, decided to forgo more money and a comfo...
Admin
14 February 2017
Kevin Lee, Director of Data Science at Clindata, has been invited to speak at the next New Jersey CD...
Admin
14 February 2017
Join us at the next PhUSE SDE in Foster City CA Theme: "Programming on Steroids” – Utilizing Advance...

Copyright © 2016   Clindata Insight Inc.   All Rights Reserved

Clindata Insight Inc, provides equal employment opportunities (EEO) to all applicants for employment without regard to race, color, religion, sex, national orgin, age, disability or genetics.  In addition to federal law requirements Clindata Insight complies with applicable state and local laws governing non discrimination in employment.

        (925) 320-7600